Evaluation of Food Effect on Pharmacokinetics of GDC-0449, an Inhibitor of Hedgehog Signaling.
Phase of Trial: Phase II
Latest Information Update: 20 May 2017
At a glance
- Drugs Vismodegib (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- 11 Apr 2017 Status changed from active, no longer recruiting to completed.
- 21 Jun 2012 Planned End Date changed from 1 Jun 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov.
- 21 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.